16 studies found for:    Isaac's Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Isaac's Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Inherited Myokymia: A Clinical and Genetic Study of a Family
Condition: A Study of Clinical and Genetic Mutations in a Family of Neuromyotonia, so Called Isaac's Syndrome
Intervention:
2 Recruiting Screening and Natural History: Primary Lateral Sclerosis and Related Disorders
Conditions: Motor Nueron Disease;   Nervous System Diseases;   Muscle Spasticity;   Diffusion Tensor Imaging;   Disease Progression;   Evoked Potentials, Motor/Physiology
Intervention:
3 Terminated Phase III Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban;   Drug: Placebo
4 Completed Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
Conditions: Primary Immunodeficiency Disorders;   Immune Thrombocytopenic Purpura (ITP);   Kawasaki Syndrome
Intervention: Procedure: Immune Globulin Intravenous (Human), 10%
5 Completed A Clinical Study of Intravenous Immunoglobulin
Condition: Immunologic Deficiency Syndromes
Intervention: Drug: Immune Globulin Intravenous (Human) Omr-IgG-am IGIV
6 Not yet recruiting Atorvastatin for HAART Suboptimal Responders
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Other: 'atorvastatin, Lipitor®';   Drug: Placebo
7 Active, not recruiting An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
Conditions: Autism;   Autistic Disorder;   Asperger's Disorder;   PDD;   Pervasive Developmental Disorder
Intervention: Drug: Gammaplex 5%
8 Recruiting Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Condition: Dumping Syndrome Patients
Intervention: Drug: SOM230
9 Recruiting ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
Condition: Coronary Artery Disease
Intervention: Device: Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices
10 Recruiting Octagam 5% Versus Comparator Post Marketing Trial
Condition: Primary Immune Deficiency Disorder
Interventions: Biological: Octagam 5%;   Biological: Other marketed IVIG product
11 Recruiting Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Conditions: Primary Immune Deficiency Disorders;   Common Variable Immunodeficiency;   X-linked Agammaglobulinaemia;   Hyper-IgM Syndrome
Interventions: Biological: Gammaplex (5%);   Biological: Gammaplex 10
12 Unknown  The Effect of Sildenafil on Sleep-Disordered Breathing in Obese Patients With Sexual Dysfunction
Conditions: Sildenafil;   Sleep Apnea;   Sexual Dysfunction;   Obesity
Intervention:
13 Unknown  The Association Between High Risk Pregnancy and Sleep-disordered Breathing
Conditions: Preeclampsia;   Gestational Diabetes;   Premature Labor
Intervention:
14 Recruiting Examining Benefits of HAART Continuation in Postpartum Mothers
Condition: HIV Infections
Intervention: Drug: Highly active antiretroviral therapy (HAART)
15 Recruiting Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting
Condition: Primary Immunodeficiency Disease (PIDD)
Intervention:
16 Recruiting Study of Octanorm Subcutaneous IG in Patients With PID
Condition: Primary Immune Deficiency Disorder
Intervention: Biological: octanorm 16.5%

Indicates status has not been verified in more than two years